12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Atreca (NASDAQ:BCEL) shares rose 45.6% to $0.34 during Thursday’s after-market session. The market value of their outstanding…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Atreca (NASDAQ:BCEL) shares increased by 102.7% to $0.22 during Thursday’s regular session. The company’s market cap stands…
Evoke Pharma Announces FDA Orange Book Listing Of New GIMOTI Patent
Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray,
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Mira Pharmaceuticals (NASDAQ:MIRA) shares moved upwards by 9.2% to $3.59 during Friday’s after-market session. The market value…
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
U.S. Patent And Trademark Office Grants Another Formulation Patent Covering GIMOTI
Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that the
Evoke Pharma: Q3 Earnings Insights
Evoke Pharma (NASDAQ:EVOK) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:30 AM. Here’s what…
Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs For Patients Using GIMOTI Over Oral Metoclopramide Presented At The American College Of Gastroenterology 2023
Evoke Pharma, Inc. (NASDAQ:EVOK),a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, and
Evoke Pharma’s Abstract Entitled “Superiority Of Nasal Spray Compared To Orally Administered Metoclopramide In Reducing Healthcare Costs In Treating Diabetic Gastroparesis Patients” To Be Presented At The American College Of Gastroenterology 2023
Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that its
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Femasys (NASDAQ:FEMY) stock increased by 104.9% to $3.12 during Friday’s regular session. Trading volume for Femasys’s stock…